These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 27446283)

  • 1. Prognostic factors affecting early colectomy in patients with moderate to severe ulcerative colitis treated with calcineurin inhibitors.
    Ban H; Bamba S; Nishida A; Inatomi O; Shioya M; Takahashi KI; Imaeda H; Murata M; Sasaki M; Tsujikawa T; Andoh A
    Exp Ther Med; 2016 Aug; 12(2):829-834. PubMed ID: 27446283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors for colectomy in refractory ulcerative colitis treated with calcineurin inhibitors.
    Bamba S; Andoh A; Imaeda H; Ban H; Kobori A; Mochizuki Y; Shioya M; Nishimura T; Inatomi O; Sasaki M; Saitoh Y; Tsujikawa T; Fujiyama Y
    Exp Ther Med; 2012 Jul; 4(1):99-104. PubMed ID: 23060930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Readministration of calcineurin inhibitors for ulcerative colitis.
    Hiraoka S; Kato J; Suzuki H; Yamamoto K
    Ann Pharmacother; 2012 Oct; 46(10):1315-21. PubMed ID: 23032660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short- and long-term efficacy of adalimumab salvage therapy after failure of calcineurin inhibitors in steroid-refractory ulcerative colitis.
    Nishio M; Ishii Y; Hashimoto Y; Otake H; Ogashiwa T; Tsuda S; Yasuhara H; Saigusa Y; Kimura H; Maeda S; Kunisaki R
    Scand J Gastroenterol; 2018; 53(10-11):1236-1244. PubMed ID: 30353757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors affecting the efficacy of cyclosporin A therapy for refractory ulcerative colitis.
    Bamba S; Tsujikawa T; Inatomi O; Nakahara T; Koizumi Y; Saitoh Y; Sasaki M; Fujiyama Y; Andoh A
    J Gastroenterol Hepatol; 2010 Mar; 25(3):494-8. PubMed ID: 20370728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of tacrolimus in hospitalized patients with steroid-refractory acute severe ulcerative colitis.
    Hoffmann P; Wehling C; Krisam J; Pfeiffenberger J; Belling N; Gauss A
    World J Gastroenterol; 2019 Apr; 25(13):1603-1617. PubMed ID: 30983820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infliximab or cyclosporine as rescue therapy in hospitalized patients with steroid-refractory ulcerative colitis: a retrospective observational study.
    Sjöberg M; Walch A; Meshkat M; Gustavsson A; Järnerot G; Vogelsang H; Hertervig E; Novacek G; Friis-Liby I; Blomquist L; Angelberger S; Karlen P; Grännö C; Vilien M; Ström M; Verbaan H; Hellström PM; Dejaco C; Magnuson A; Halfvarson J; Reinisch W; Tysk C
    Inflamm Bowel Dis; 2012 Feb; 18(2):212-8. PubMed ID: 21438096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term efficacy of tacrolimus in steroid-refractory ulcerative colitis - experience in 130 patients.
    Schmidt KJ; Herrlinger KR; Emmrich J; Barthel D; Koc H; Lehnert H; Stange EF; Fellermann K; Büning J
    Aliment Pharmacol Ther; 2013 Jan; 37(1):129-36. PubMed ID: 23121200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inpatient Therapy With Calcineurin Inhibitors in Severe Ulcerative Colitis.
    Dwadasi S; Zafer M; Goens D; Paknikar R; Dalal S; Cohen RD; Pekow J; Rubin DT; Sakuraba A; Micic D
    Inflamm Bowel Dis; 2021 Oct; 27(10):1620-1625. PubMed ID: 33319248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effectiveness and safety of rescue treatments in 108 patients with steroid-refractory ulcerative colitis with sequential rescue therapies in a subgroup of patients.
    Protic M; Seibold F; Schoepfer A; Radojicic Z; Juillerat P; Bojic D; Mwinyi J; Mottet C; Jojic N; Beglinger C; Vavricka S; Rogler G; Frei P
    J Crohns Colitis; 2014 Nov; 8(11):1427-37. PubMed ID: 24908178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short- and Long-Term Outcomes of Infliximab Treatment for Steroid-Refractory Ulcerative Colitis and Related Prognostic Factors: A Single-Center Retrospective Study.
    Nasuno M; Miyakawa M; Tanaka H; Motoya S
    Digestion; 2017; 95(1):67-71. PubMed ID: 28052276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacologic therapies for severe steroid refractory hospitalized ulcerative colitis: A network meta-analysis.
    Komaki Y; Komaki F; Micic D; Yamada A; Suzuki Y; Sakuraba A
    J Gastroenterol Hepatol; 2017 Jun; 32(6):1143-1151. PubMed ID: 27957761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term Outcomes in Steroid-refractory Ulcerative Colitis Treated with Tacrolimus Alone or in Combination with Purine Analogues.
    Schmidt KJ; Müller N; Dignass A; Baumgart DC; Lehnert H; Stange EF; Herrlinger KR; Fellermann K; Büning J
    J Crohns Colitis; 2016 Jan; 10(1):31-7. PubMed ID: 26419459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and Safety of Induction Therapy With Calcineurin Inhibitors in Combination With Vedolizumab in Patients With Refractory Ulcerative Colitis.
    Pellet G; Stefanescu C; Carbonnel F; Peyrin-Biroulet L; Roblin X; Allimant C; Nachury M; Nancey S; Filippi J; Altwegg R; Brixi H; Fotsing G; de Rosamel L; Shili S; Laharie D;
    Clin Gastroenterol Hepatol; 2019 Feb; 17(3):494-501. PubMed ID: 30213584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors predictive of response to cyclosporin treatment for severe, steroid-resistant ulcerative colitis.
    Rowe FA; Walker JH; Karp LC; Vasiliauskas EA; Plevy SE; Targan SR
    Am J Gastroenterol; 2000 Aug; 95(8):2000-8. PubMed ID: 10950049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steroid-refractory ulcerative colitis: predictive factors of response to cyclosporine and validation in an independent cohort.
    Aceituno M; García-Planella E; Heredia C; Zabana Y; Feu F; Domènech E; Gassull MA; Panés J
    Inflamm Bowel Dis; 2008 Mar; 14(3):347-52. PubMed ID: 18050296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of colectomy during long-term follow-up after cyclosporine-induced remission of severe ulcerative colitis.
    Moskovitz DN; Van Assche G; Maenhout B; Arts J; Ferrante M; Vermeire S; Rutgeerts P
    Clin Gastroenterol Hepatol; 2006 Jun; 4(6):760-5. PubMed ID: 16716758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infliximab in ulcerative colitis: real-life analysis of factors predicting treatment discontinuation due to lack of response or colectomy: ECIA (ACAD Colitis and Infliximab Study).
    Fernández-Salazar L; Muñoz F; Barrio J; Muñoz C; Pajares R; Rivero M; Prieto V; Legido J; Bouhmidi A; Herranz M; Fernández N; Sánchez-Ocaña R; Joao D; Santos F
    Scand J Gastroenterol; 2016; 51(2):186-95. PubMed ID: 26200929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The efficacy of cyclosporine A as salvage therapy for severe active ulcerative colitis refractory to glucocorticoid].
    Li J; Wei MM; Fei GJ; Feng YL; Yang H; Li Y; Lyu G; Shu HJ; Qian JM
    Zhonghua Nei Ke Za Zhi; 2017 Apr; 56(4):279-283. PubMed ID: 28355721
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-Term Outcomes of Immunosuppression-Naïve Steroid Responders Following Hospitalization for Ulcerative Colitis.
    Vedamurthy A; Xu L; Luther J; Colizzo F; Garber JJ; Khalili H; Ananthakrishnan AN
    Dig Dis Sci; 2018 Oct; 63(10):2740-2746. PubMed ID: 29951797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.